Trial
NCT00217464
Fulvestrant in Treating Patients With Recurrent Prostate Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Prostate Cancer
Intervention
fulvestrant
Why stopped
Closed for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-16